Marfan syndrome: genes and variants
Condition overview
Marfan syndrome affects connective tissue, including the aorta, eyes and skeleton. FBN1 is the established causal gene; inheritance is autosomal dominant.
This atlas retains source records and historical labels, including ‘Marfan syndrome type 2’. TGFBR1 and TGFBR2 are associated with Loeys–Dietz syndrome. Their appearance here does not establish them as causes of classic Marfan syndrome.
MedlinePlus: Marfan syndrome · MedlinePlus: Loeys–Dietz syndrome
Explore variant evidence for Marfan syndrome across 3 analyzed proteins (FBN1, TGFBR2, TGFBR1). Linked ClinVar records include 439 pathogenic or likely pathogenic variants, 942 variants of uncertain significance and 175 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Marfan syndrome
FBN1: Fibrillin-1
Its fibrillin-1 microfibrils provide mechanical support to elastic tissues and regulate local availability of growth factors such as TGF-beta. Pathogenic variants cause Marfan syndrome and related fibrillinopathies affecting the aorta, skeleton, eyes, skin, and lungs.
434 ClinVar pathogenic / likely pathogenic and 1,113 uncertain variants in FBN1 have source records linked to Marfan syndrome. Association strength is not clinical gene validity.
TGFBR2: TGF-beta receptor type-2
It binds TGF-beta ligands and activates TGFBR1 to initiate canonical and noncanonical signaling. Germline pathogenic variants cause Loeys-Dietz syndrome type 2, while somatic loss can remove growth-suppressive TGF-beta responses in cancer.
3 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in TGFBR2 have source records linked to Marfan syndrome. Association strength is not clinical gene validity.
TGFBR1: TGF-beta receptor type-1
After activation by the ligand-bound receptor complex, it phosphorylates SMAD2 and SMAD3 to propagate TGF-beta signals. Germline pathogenic variants cause Loeys-Dietz syndrome type 1 with arterial aneurysm and dissection and variable craniofacial or skeletal features.
2 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in TGFBR1 have source records linked to Marfan syndrome. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): COL5A1, COL5A2, FBN2 and NOTCH1.
ClinVar pathogenic and likely pathogenic variants linked to Marfan syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| FBN1 C887Y | 887 | TB 4 | Pathogenic / likely pathogenic (★★★) |
| FBN1 C2470F | 2470 | EGF-like 42 | Pathogenic / likely pathogenic (★★★) |
| FBN1 C67R | 67 | Fibrillin unique N-terminal (FUN) domain | Pathogenic / likely pathogenic (★★★) |
| FBN1 C570R | 570 | EGF-like 8 | Pathogenic / likely pathogenic (★★★) |
| FBN1 C1470Y | 1470 | EGF-like 25 | Pathogenic / likely pathogenic (★★★) |
| FBN1 C476Y | 476 | EGF-like 6 | Pathogenic / likely pathogenic (★★) |
| FBN1 C494W | 494 | EGF-like 7 | Pathogenic / likely pathogenic (★★) |
| FBN1 C1577Y | 1577 | TB 6 | Pathogenic / likely pathogenic (★★) |
| FBN1 C2258G | 2258 | EGF-like 39 | Pathogenic / likely pathogenic (★★) |
| FBN1 C541Y | 541 | EGF-like 8 | Pathogenic / likely pathogenic (★★) |
| FBN1 C557W | 557 | EGF-like 8 | Pathogenic / likely pathogenic (★★) |
| FBN1 C582Y | 582 | EGF-like 9 | Pathogenic / likely pathogenic (★★) |
| FBN1 C596Y | 596 | EGF-like 9 | Pathogenic / likely pathogenic (★★) |
| FBN1 C628Y | 628 | EGF-like 10 | Pathogenic / likely pathogenic (★★) |
| FBN1 C628W | 628 | EGF-like 10 | Pathogenic / likely pathogenic (★★) |
| FBN1 E726G | 726 | EGF-like 11 | Pathogenic / likely pathogenic (★★) |
| FBN1 C792Y | 792 | EGF-like 12 | Pathogenic / likely pathogenic (★★) |
| FBN1 C792R | 792 | EGF-like 12 | Pathogenic / likely pathogenic (★★) |
| FBN1 C832F | 832 | EGF-like 13 | Pathogenic / likely pathogenic (★★) |
| FBN1 R954L | 954 | Pathogenic / likely pathogenic (★★) | |
| FBN1 C1265Y | 1265 | EGF-like 20 | Pathogenic / likely pathogenic (★★) |
| FBN1 C1307Y | 1307 | EGF-like 21 | Pathogenic / likely pathogenic (★★) |
| FBN1 G1310D | 1310 | EGF-like 21 | Pathogenic / likely pathogenic (★★) |
| FBN1 C1491F | 1491 | EGF-like 26 | Pathogenic / likely pathogenic (★★) |
| FBN1 C1853R | 1853 | EGF-like 31 | Pathogenic / likely pathogenic (★★) |
| FBN1 D1891N | 1891 | EGF-like 32 | Pathogenic / likely pathogenic (★★) |
| FBN1 C1914Y | 1914 | EGF-like 32 | Pathogenic / likely pathogenic (★★) |
| FBN1 D1930G | 1930 | EGF-like 33 | Pathogenic / likely pathogenic (★★) |
| FBN1 C2232S | 2232 | EGF-like 38 | Pathogenic / likely pathogenic (★★) |
| FBN1 C315R | 315 | EGF-like 5 | Pathogenic / likely pathogenic (★★) |
| FBN1 N741K | 741 | EGF-like 11 | Pathogenic / likely pathogenic (★★) |
| FBN1 C914Y | 914 | EGF-like 14 | Pathogenic / likely pathogenic (★★) |
| FBN1 C1622R | 1622 | EGF-like 27 | Pathogenic / likely pathogenic (★★) |
| FBN1 C67F | 67 | Fibrillin unique N-terminal (FUN) domain | Pathogenic / likely pathogenic (★★) |
| FBN1 C102Y | 102 | EGF-like 1 | Pathogenic / likely pathogenic (★★) |
| FBN1 C119Y | 119 | EGF-like 2 | Pathogenic / likely pathogenic (★★) |
| FBN1 C154Y | 154 | EGF-like 3 | Pathogenic / likely pathogenic (★★) |
| FBN1 C166Y | 166 | EGF-like 3 | Pathogenic / likely pathogenic (★★) |
| FBN1 C476W | 476 | EGF-like 6 | Pathogenic / likely pathogenic (★★) |
| FBN1 D723G | 723 | EGF-like 11 | Pathogenic / likely pathogenic (★★) |
| FBN1 C750Y | 750 | EGF-like 11 | Pathogenic / likely pathogenic (★★) |
| FBN1 C830F | 830 | EGF-like 13 | Pathogenic / likely pathogenic (★★) |
| FBN1 C926R | 926 | EGF-like 14 | Pathogenic / likely pathogenic (★★) |
| FBN1 N1046S | 1046 | EGF-like 15 | Pathogenic / likely pathogenic (★★) |
| FBN1 E1241K | 1241 | EGF-like 20 | Pathogenic / likely pathogenic (★★) |
| FBN1 C1278S | 1278 | EGF-like 20 | Pathogenic / likely pathogenic (★★) |
| FBN1 C1374G | 1374 | EGF-like 23 | Pathogenic / likely pathogenic (★★) |
| FBN1 C1389Y | 1389 | EGF-like 23 | Pathogenic / likely pathogenic (★★) |
| FBN1 C1402G | 1402 | EGF-like 23 | Pathogenic / likely pathogenic (★★) |
| FBN1 D1406G | 1406 | EGF-like 24 | Pathogenic / likely pathogenic (★★) |
| FBN1 C1513G | 1513 | EGF-like 26 | Pathogenic / likely pathogenic (★★) |
| FBN1 C1526R | 1526 | EGF-like 26 | Pathogenic / likely pathogenic (★★) |
| FBN1 C1687F | 1687 | EGF-like 28 | Pathogenic / likely pathogenic (★★) |
| FBN1 C1695W | 1695 | TB 7 | Pathogenic / likely pathogenic (★★) |
| FBN1 C1721Y | 1721 | TB 7 | Pathogenic / likely pathogenic (★★) |
| FBN1 C1818Y | 1818 | EGF-like 30 | Pathogenic / likely pathogenic (★★) |
| FBN1 C1905F | 1905 | EGF-like 32 | Pathogenic / likely pathogenic (★★) |
| FBN1 C1905S | 1905 | EGF-like 32 | Pathogenic / likely pathogenic (★★) |
| FBN1 C1928R | 1928 | EGF-like 32 | Pathogenic / likely pathogenic (★★) |
| FBN1 C1934R | 1934 | EGF-like 33 | Pathogenic / likely pathogenic (★★) |
Showing 60 of 439.
Uncertain variants prioritized for review in Marfan syndrome
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| FBN1 D1363V | 1363 | EGF-like 23 | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; D1363Y at the same position is pathogenic; REVEL 0.979 |
| FBN1 L879R | 879 | TB 4 | Uncertain (★) | +6: 4 other pathogenic changes within 3 positions; L879P at the same position is pathogenic; REVEL 0.920 |
| FBN1 R2220L | 2220 | EGF-like 38 | Uncertain (★★) | +6: 5 other pathogenic changes within 3 positions; R2220P at the same position is pathogenic; REVEL 0.817 |
Which prediction tools work for Marfan syndrome
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- CATVariant: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 99 out of 100
- MutPred: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 95 out of 100
- REVEL: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 90 out of 100
- SIFT: 88 out of 100
- PolyPhen-2: 80 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 75 out of 100
- Pangolin: 52 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 49 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Isolated thoracic aortic aneurysm also has ClinVar records linked to FBN1 variants; they fall in the same places as the Marfan syndrome variants (12 pathogenic / likely pathogenic).
- Marfan syndrome/loeys-dietz syndrome/familial thoracic aortic aneurysms and dissections also has ClinVar records linked to FBN1 variants; they fall mostly in different places as the Marfan syndrome variants (10 pathogenic / likely pathogenic).
- Acromicric dysplasia also has ClinVar records linked to FBN1 variants; they fall partly in the same places as the Marfan syndrome variants (6 pathogenic / likely pathogenic).
- Ectopia lentis 1, isolated, autosomal dominant also has ClinVar records linked to FBN1 variants; they fall partly in the same places as the Marfan syndrome variants (6 pathogenic / likely pathogenic).
- Geleophysic dysplasia also has ClinVar records linked to FBN1 variants; they fall in the same places as the Marfan syndrome variants (6 pathogenic / likely pathogenic).
- Familial thoracic aortic aneurysm and aortic dissection also has ClinVar records linked to TGFBR2 variants; they fall mostly in different places as the Marfan syndrome variants (78 pathogenic / likely pathogenic).
- Loeys-Dietz syndrome also has ClinVar records linked to TGFBR2 variants; they fall mostly in different places as the Marfan syndrome variants (49 pathogenic / likely pathogenic).
- Ehlers-Danlos syndrome also has ClinVar records linked to TGFBR2 variants; they fall mostly in different places as the Marfan syndrome variants (4 pathogenic / likely pathogenic).
- Loeys-Dietz syndrome also has ClinVar records linked to TGFBR1 variants; they fall mostly in different places as the Marfan syndrome variants (23 pathogenic / likely pathogenic).
- Familial thoracic aortic aneurysm and aortic dissection also has ClinVar records linked to TGFBR1 variants; they fall mostly in different places as the Marfan syndrome variants (23 pathogenic / likely pathogenic).
Diseases related to Marfan syndrome
- Familial thoracic aortic aneurysm and aortic dissection, also linked to FBN1, TGFBR1 and TGFBR2
- Ehlers-Danlos syndrome, also linked to TGFBR1 and TGFBR2
- Loeys-Dietz syndrome, also linked to TGFBR1 and TGFBR2
- Familial aortopathy, also linked to FBN1 and TGFBR1
- Lynch syndrome, also linked to TGFBR2
- Perrault syndrome, also linked to FBN1
- Connective tissue disease, also linked to FBN1
- Parkinson disease, also linked to TGFBR2
- Isolated thoracic aortic aneurysm, also linked to FBN1
- Marfan syndrome/loeys-dietz syndrome/familial thoracic aortic aneurysms and dissections, also linked to FBN1
- Acromicric dysplasia, also linked to FBN1
- Ectopia lentis 1, isolated, autosomal dominant, also linked to FBN1
Frequently asked questions
Which genes have records linked to Marfan syndrome?
This view contains 3 analyzed proteins: FBN1, TGFBR2, TGFBR1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 439 pathogenic or likely pathogenic variants, 942 variants of uncertain significance and 175 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 3 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 1,782 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center